Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for low bone density in adults with cerebral palsy
ACTRN12615001048572Phase 4Not yet recruiting
- Sponsor
- Anne Trinh
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zoledronic acid in osteoporosis (2 arms), sponsored by Anne Trinh. Primary endpoint: Change in bone mineral density by DXA. Planned start Feb 2016; status: not yet recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ACTRN12615001048572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001048572.